Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Title Grant Type Focus Area Country Application Due Date Providing Access to Learning Resources for Nurses in AfricaRelease Date:Review Process:Increasing Adult Pneumococcal Immunization Rates through AAFP State ChaptersRelease Date:Improving Vaccine Utilization and Preventive Health Maintenance in IBDRelease Date:Review Process:Supporting Educational Programs for Radical Reform of Pain Treatment in JapanRelease Date:Review Process:Improving Pediatric Immunization Care – Innovative Strategies to Improve Childhood Immunization RatesRelease Date:Review Process:Rheumatology Nurse Practitioner and Physician Assistant FellowshipRelease Date:Review Process:Cardiac Amyloidosis FellowshipRelease Date:Review Process:Improving Pneumococcal Immunization of Adults with Immunocompromising ConditionsRelease Date:Review Process:Efforts for Early Detection of Atrial Fibrillation and Prevention of Cardio Embolic StrokeRelease Date:Review Process:Quality Improvement Activities to Prevent Fatal Pulmonary ThromboembolismRelease Date:Review Process:Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEingRelease Date:Review Process:QI Initiaitives Focused on Undiagnosed Nonvalvular Atrial Fibrillation (NVAF)Release Date:Review Process: